Malignant melanoma is a highly aggressive tumor with increasing incidence and high mortality. The importance of immunohistochemistry in diagnosis of the primary tumor and in early identification of metastases in lymphatic nodes is enormous; however melanoma phenotype is frequently variable and thus several markers must be employed simultaneously. The purposes of this study are to describe changes of phenotype of malignant melanoma in vitro and in vivo and to investigate whether changes of environmental factors mimicking natural conditions affect the phenotype of melanoma cells and can revert the typical in vitro loss of diagnostic markers. The influence of microenvironment was studied by means of immunocytochemistry on co-cultures of melanoma cells with melanoma-associated fibroblast and/or in conditioned media. The markers typical for melanoma (HMB45, Melan-A, Tyrosinase) were lost in malignant cells isolated from malignant effusion; however, tumor metastases shared identical phenotype with primary tumor (all markers positive). The melanoma cell lines also exerted reduced phenotype in vitro. The only constantly present diagnostic marker observed in our experiment was S100 protein and, in lesser extent, also Nestin. The phenotype loss was reverted under the influence of melanoma-associated fibroblast and/or both types of conditioned media. Loss of some markers of melanoma cell phenotype is not only of diagnostic significance, but it can presumably also contribute to biological behavior of melanoma. The presented study shows how the conditions of cultivation of melanoma cells can influence their phenotype. This observation can have some impact on considerations about the role of microenvironment in tumor biology.

1st Faculty of Medicine Department of Dermatovenereology Charles University Prague Czech Republic

Zobrazit více v PubMed

Melanoma Res. 2012 Oct;22(5):334-40 PubMed

Genes Dev. 2004 Aug 1;18(15):1875-85 PubMed

Folia Biol (Praha). 2010;56(4):149-57 PubMed

Int J Mol Med. 2005 Oct;16(4):525-31 PubMed

Dev Dyn. 2004 Oct;231(2):258-69 PubMed

Cancer Immunol Immunother. 2009 May;58(5):665-75 PubMed

Br J Dermatol. 2007 May;156(5):819-29 PubMed

C R Acad Hebd Seances Acad Sci D. 1970 Jun 22;270(25):3095-8 PubMed

Am J Pathol. 1993 Dec;143(6):1579-85 PubMed

Clin Exp Metastasis. 1991 May-Jun;9(3):259-72 PubMed

J Dtsch Dermatol Ges. 2011 Sep;9(9):690-9 PubMed

Stem Cells. 2011 Jan;29(1):46-56 PubMed

Arch Dermatol. 2010 Oct;146(10):1156-7 PubMed

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4329-34 PubMed

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3752-7 PubMed

Science. 2005 Feb 4;307(5710):720-4 PubMed

Hum Pathol. 2005 Sep;36(9):1016-9 PubMed

Diagn Pathol. 2012 Jul 17;7:82 PubMed

Diagn Pathol. 2011 Aug 11;6:76 PubMed

Nature. 2002 Apr 25;416(6883):854-60 PubMed

Nat Rev Cancer. 2007 Apr;7(4):246-55 PubMed

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12396-400 PubMed

Pigment Cell Melanoma Res. 2012 Sep;25(5):573-83 PubMed

Histochem Cell Biol. 2010 Feb;133(2):201-11 PubMed

Stem Cells. 2005 Sep;23(8):1200-11 PubMed

Stem Cells. 2012 Feb;30(2):336-43 PubMed

Eur J Cancer. 2009 Nov;45(16):2736-42 PubMed

Histochem Cell Biol. 2012 May;137(5):679-85 PubMed

Pediatr Res. 2009 Apr;65(4):458-61 PubMed

Proc Natl Acad Sci U S A. 1976 Feb;73(2):549-53 PubMed

Br J Dermatol. 2012 Nov;167(5):1124-30 PubMed

PLoS One. 2011 Apr 15;6(4):e18784 PubMed

Dev Dyn. 2005 Aug;233(4):1560-70 PubMed

Arch Dermatol. 2010 Oct;146(10):1120-4 PubMed

Mod Pathol. 2013 Jan;26(1):44-53 PubMed

Ann Surg Oncol. 2012 Apr;19(4):1089-99 PubMed

Melanoma Res. 2009 Aug;19(4):215-25 PubMed

PLoS One. 2012;7(7):e41052 PubMed

Am J Surg Pathol. 2002 Jan;26(1):82-7 PubMed

Surgery. 2011 Jul;150(1):83-90 PubMed

Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study

Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes

Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts

Intercellular crosstalk in human malignant melanoma

Cancer Microenvironment: What Can We Learn from the Stem Cell Niche